{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:35:38Z","timestamp":1773696938956,"version":"3.50.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008252","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:36:05Z","timestamp":1593711365000},"page":"e0008252","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-4029","authenticated-orcid":true,"given":"Robert K. M.","family":"Choy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"pntd.0008252.ref001","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0016-5085(76)80503-3","article-title":"Acute enterocolitis in a human being infected with the protozoan Cryptosporidium","volume":"70","author":"FA Nime","year":"1976","journal-title":"Gastroenterology"},{"key":"pntd.0008252.ref002","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199407213310304","article-title":"A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply","volume":"331","author":"WR MacKenzie","year":"1994","journal-title":"New Engl J Med"},{"key":"pntd.0008252.ref003","doi-asserted-by":"crossref","first-page":"547","DOI":"10.15585\/mmwr.mm6719a3","article-title":"Outbreaks associated with treated recreational water\u2014United States, 2000\u20132014","volume":"67","author":"MC Hlavsa","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"pntd.0008252.ref004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"KL Kotloff","year":"2013","journal-title":"Lancet"},{"key":"pntd.0008252.ref005","doi-asserted-by":"crossref","first-page":"P1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"J Liu","year":"2016","journal-title":"Lancet"},{"key":"pntd.0008252.ref006","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"JA Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"key":"pntd.0008252.ref007","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2214-109X(18)30283-3","article-title":"Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study","volume":"6","author":"IA Khalil","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pntd.0008252.ref008","doi-asserted-by":"crossref","first-page":"PE204","DOI":"10.1016\/S2214-109X(19)30541-8","article-title":"Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study","volume":"8","author":"MM Levine","year":"2020","journal-title":"Lancet Glob Health"},{"key":"pntd.0008252.ref009","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2125.2007.02873.x","article-title":"Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta\u2010analysis","volume":"63","author":"I Abubakar","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"pntd.0008252.ref010","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"B Amadi","year":"2002","journal-title":"Lancet"},{"key":"pntd.0008252.ref011","doi-asserted-by":"crossref","first-page":"e0005373","DOI":"10.1371\/journal.pntd.0005373","article-title":"A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis","volume":"11","author":"MS Love","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008252.ref012","article-title":"The development process for discovery and clinical advancement of modern antimalarials","author":"TD Ashton","year":"2019","journal-title":"J Med Chem"},{"key":"pntd.0008252.ref013","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-2846-6","article-title":"Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial","volume":"19","author":"P Nachipo","year":"2018","journal-title":"Trials"},{"key":"pntd.0008252.ref014","unstructured":"A phase 2A, randomized, double-blind, placebo-controlled evaluation of the safety, tolerability, pharmacokinetics and efficacy of clofazimine (CFZ) in cryptosporidiosis. Identifier: NCT03341767. First posted 2017 Nov 14 [cited 2019 Nov 11]. Clinical Trials.gov [Internet]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT03341767."},{"key":"pntd.0008252.ref015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"UH Manjunatha","year":"2017","journal-title":"Nature"},{"key":"pntd.0008252.ref016","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1038\/s41467-019-10687-y","article-title":"Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis","volume":"10","author":"CS Lunde","year":"2019","journal-title":"Nat Commun"},{"key":"pntd.0008252.ref017","doi-asserted-by":"crossref","first-page":"e1007315","DOI":"10.1371\/journal.ppat.1007315","article-title":"The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing","volume":"14","author":"D Begolo","year":"2018","journal-title":"PLoS Pathog"},{"key":"pntd.0008252.ref018","doi-asserted-by":"crossref","first-page":"eaax7161","DOI":"10.1126\/scitranslmed.aax7161","article-title":"Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls Cryptosporidium infection","volume":"11","author":"C Swale","year":"2019","journal-title":"Sci Transl Med"},{"key":"pntd.0008252.ref019","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/acs.jmedchem.9b00069","article-title":"Development of 5-aminopyrazole-4-carboxamide-based bumped-kinase inhibitors for cryptosporidiosis therapy","volume":"62","author":"W Huang","year":"2019","journal-title":"J Med Chem"},{"key":"pntd.0008252.ref020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijpara.2017.08.006","article-title":"Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis","volume":"47","author":"MA Hulverson","year":"2017","journal-title":"Int J Parasitol"},{"key":"pntd.0008252.ref021","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1073\/pnas.1814685116","article-title":"Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis","volume":"116","author":"B Baraga\u00f1a","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"pntd.0008252.ref022","unstructured":"Vinayak S, Jumani RS, Miller P, Hasan MM, McLeod BI, et al. Phenylalanyl-tRNA synthetase (PheRS), a novel drug target for Cryptosporidium: discovery of therapeutically relevant inhibitors with genetic, biochemical and chemical target validation. [Manuscript submitted November 2019]"},{"key":"pntd.0008252.ref023","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/infdis\/jiz105","article-title":"Piperazine-derivative MMV665917: an effective drug in the diarrheic piglet model of Cryptosporidium hominis","volume":"220","author":"S Lee","year":"2019","journal-title":"J Infect Dis"},{"key":"pntd.0008252.ref024","doi-asserted-by":"crossref","first-page":"e01505","DOI":"10.1128\/AAC.01505-17","article-title":"A novel piperazine-based drug lead for cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box","volume":"62","author":"RS Jumani","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008252.ref025","doi-asserted-by":"crossref","first-page":"e0006183","DOI":"10.1371\/journal.pntd.0006183","article-title":"Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model","volume":"12","author":"E Stebbins","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008252.ref026","doi-asserted-by":"crossref","first-page":"e02061","DOI":"10.1128\/AAC.02061-18","article-title":"Optimization of methionyl tRNA-synthetase inhibitors for treatment of Cryptosporidium infection","volume":"63","author":"FS Buckner","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0008252.ref027","doi-asserted-by":"crossref","DOI":"10.1128\/9781555816339","volume-title":"Forgotten people, forgotten diseases: The neglected tropical diseases and their impact on global health and development","author":"PJ Hotez","year":"2008"},{"key":"pntd.0008252.ref028","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1377\/hlthaff.25.2.313","article-title":"Developing drugs for developing countries","volume":"25","author":"DB Ridley","year":"2006","journal-title":"Health Affairs"},{"key":"pntd.0008252.ref029","unstructured":"Comment from Novartis Institute for Tropical Diseases: Cryptosporidiosis briefing document; 2019 [cited 2019 Nov 10]. Registration.gov [Internet]. Available from: https:\/\/www.regulations.gov\/document?D = FDA-2008-N-0567-0148."},{"key":"pntd.0008252.ref030","unstructured":"US Department of Health and Human Services, US Food and Drug Administration. Tropical disease priority review vouchers: Guidance for industry. OMB Control No. 0910\u20130822. Silver Spring, MD: US Food and Drug Administration; 2016."},{"key":"pntd.0008252.ref031","doi-asserted-by":"crossref","first-page":"568","DOI":"10.15585\/mmwr.mm6825a3","article-title":"Cryptosporidiosis outbreaks\u2014United States, 2009\u20132017","volume":"68","author":"R Gharpure","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"pntd.0008252.ref032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid1701.P11101","article-title":"Foodborne illness acquired in the United States\u2014major pathogens","volume":"17","author":"E Scallan","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"pntd.0008252.ref033","doi-asserted-by":"crossref","first-page":"e0004729","DOI":"10.1371\/journal.pntd.0004729","article-title":"The burden of Cryptosporidium diarrheal disease among children < 24 months of age in moderate\/high mortality regions of sub-Saharan Africa and South Asia, utilizing data from the Global Enteric Multicenter Study (GEMS)","volume":"10","author":"SO Sow","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008252.ref034","doi-asserted-by":"crossref","first-page":"e0006837","DOI":"10.1371\/journal.pntd.0006837","article-title":"Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years","volume":"12","author":"PL Olliaro","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008252.ref035","unstructured":"PATH, Clarus, and the Global Health Investment Fund announce an innovative $25 million financing arrangement to improve treatment of intestinal worms, affecting more than 1 billion people worldwide. 2017 Jan 31 [cited 2019 Nov 10]. In: PATH Media Center [Internet]. Seattle, WA: PATH. [About 3 screens.] Available from: https:\/\/www.path.org\/media-center\/path-clarus-and-the-global-health-investment-fund-announce-an-innovative-25-million-financing-arrangement-to-improve-treatment-of-intestinal-worms-affecting-more-than-1-billion-people-worldwide\/."},{"key":"pntd.0008252.ref036","unstructured":"PaxVax, Inc. announces $105 million investment from Cerberus Capital Management. 2015 Dec 8 [cited 2019 Nov 10]. In: PR Newswire [Internet]. Cerberus Capital Management, L.P. [About 2 screens.] Available from: https:\/\/www.prnewswire.com\/news-releases\/paxvax-inc-announces-105-million-investment-from-cerberus-capital-management-300189666.html."}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:36:18Z","timestamp":1593711378000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008252"}},"subtitle":[],"editor":[{"given":"Rana","family":"Nagarkatti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008252","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}